TheEdgeResearch
Home / Stocks / XBIT

XBiotech Inc. (XBIT)

NASDAQ Healthcare Biotechnology
$1.73 ▲ +2.98%
Market Cap
$52.7M
Sector
Healthcare
Industry
Biotechnology
Beta
0.74
52-Wk Range
1.61-2.73
CEO
Sushma Shivaswamy
Country
US
Currency
USD

XBiotech Inc. operates in the Biotechnology industry of the Healthcare sector, headquartered in Austin, TX, US. The stock last traded at $1.73, up 2.98% on the session, giving a market capitalisation of $52.7M. On trailing twelve-month figures it carries a trailing P/E of -1.21, a net margin of 0.0%. Its beta of 0.74 implies it has historically moved less than the broad market.

Valuation & profitability (TTM)
P/E
-1.21
Price / Sales
0.00
Price / Book
0.43
EV / EBITDA
1.30
Gross margin
0.0%
Operating margin
0.0%
Net margin
0.0%
Return on equity
—
Debt / equity
0.00
Current ratio
39.51
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
NASDAQ Global Select
Employees
85
IPO date
2015-04-15
Headquarters
Austin, TX, US
About XBiotech Inc.

XBiotech Inc. is a biopharmaceutical firm specializing in the discovery, development, and commercialization of True Human monoclonal antibodies. Their primary focus involves building a robust pipeline of product candidates aimed at combating both inflammatory and infectious diseases. Furthermore, the company is advancing interleukin-1 alpha-based therapies, which are designed to address a broad spectrum of medical conditions such as cancer, stroke, heart attack, and arthritis. Interleukin-1 alpha itself plays a crucial role in biological processes like tissue breakdown, angiogenesis, blood clot formation, malaise, muscle wasting, and inflammation. Additionally, XBiotech is developing a True Human COVID-19 therapy specifically targeting mutant strains of the virus. Established in 2005, XBiotech Inc. maintains its headquarters in Austin, Texas.

Comparable companies

XBiotech Inc. is most often compared with the following Healthcare names:

ACETACRVADAGCRVOFBIOGANXLITSNTRBRLMDTCRX
More research on XBIT
XBIT technical analysis XBIT TheEdge Score Compare against peers
Open full interactive analysis & DCF →